The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Aralez Pharmaceuticals Inc

TSX: ARZ
Delayed quote

$2.02

Today's change+0.03 +1.51%
Updated October 17 3:59 PM EDT. Delayed by at least 15 minutes.
 

Aralez Pharmaceuticals Inc

TSX: ARZ
Delayed quote

$2.02

Today's change+0.03 +1.51%
Updated October 17 3:59 PM EDT. Delayed by at least 15 minutes.

Aralez Pharmaceuticals Inc up sharply

Aralez Pharmaceuticals Inc closed up sharply Tuesday, rallying $0.03 or 1.51% to $2.02. Over the last five days, shares have lost 28.87% and are down 65.82% for the last year to date. This security has underperformed the S&P TSX by 75.41% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$1.63
Updated October 17 3:59 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-122.35%

Aralez Pharmaceuticals Inc has a net profit margin of -122.35%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.09%Sector:Industry:

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue28262014
Total other revenue--------
Total revenue28262014
Gross profit25231810
Total cost of revenue3333
Total operating expense48474833
Selling / general / administrative32313325
Research & development1012
Depreciation / amortization9972
Interest expense (income), net operating--------
Unusual expense (income)----4--
Other operating expenses, total441--
Operating income-20-21-28-20
Interest income (expense), net non-operating-7-7-50
Gain (loss) on sale of assets--------
Other--------
Income before tax-27-27-32-20
Income after tax-28-27-31-21
Income tax, total01-10
Net income-28-27-31-21
Total adjustments to net income--------
Net income before extra. items-28-27-31-21
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-28-27-31-21
Inc. avail. to common incl. extra. items-28-27-31-21
Diluted net income-28-27-31-21
Dilution adjustment--------
Diluted weighted average shares66666665
Diluted EPS excluding extraordinary itemsvalue per share-0.42-0.42-0.47-0.32
Dividends per sharevalue per share--0.00--0.00
Diluted normalized EPSvalue per share-0.42-0.42-0.43-0.32